STOCK TITAN

Sage Therapeutics to Present at Upcoming September Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Sage Therapeutics to present at investor conferences in September
Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will present at the following upcoming investor conferences in September:

  • Morgan Stanley 21st Annual Global Healthcare Conference (New York, NY): fireside chat on Wednesday, September 13, 2023 at 12:15 p.m. ET.
  • TD Cowen 3rd Annual Novel Mechanisms in Neuropsychiatry Summit (Virtual): fireside chat on Wednesday, September 20, 2023 at 3:00 p.m. ET.

A live webcast of each event can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcasts will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Investors

Ashley Kaplowitz

786-252-1419

ashley.kaplowitz@sagerx.com

Media Contact

Matthew Henson

917-930-7147

matthew.henson@sagerx.com

Source: Sage Therapeutics, Inc.

Sage Therapeutics, Inc

NASDAQ:SAGE

SAGE Rankings

SAGE Latest News

SAGE Stock Data

349.66M
60.18M
11.9%
90.31%
10.01%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
CAMBRIDGE